NEUROSCIENTISTS have discovered they can estimate when Alzheimer’s is most likely to strike a person, based on his or her sleep pattern. The best defense:
BREAKTHROUGH: FOR THE FIRST TIME in 18 years, the FDA approved a new Alzheimer’s drug. The new medication’s generic name is aducanumab and will be marketed under the brand name Aduhelm. Another first is the drug’s ability to potentially slow down Alzheimer’s, not just cover up its symptoms, as existing medications do. Find out more.
ADVANCES IN DEMENTIA CARE – VIDEO: Dementia-Villages are catching on, with France building the largest one yet. At $28 million, take a quick look at
BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a “Breakthrough Therapy” designation for donanemab, a potential new treatment for people with early symptomatic
BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so
DIAGNOSIS: The PrecivityAD™ blood test accurately and reliably detected brain amyloid on a single blood sample. Intended for people with memory and thinking issues, the
RESEARCH: Scientists are using gold nanoparticles to create new images of the amyloid fibrils associated with Alzheimer’s disease and other neurodegenerative disorders. The fibrils are
Researchers studying Australians with type 2 diabetes found those taking the first-line treatment medication metformin had significantly slower cognitive decline compared to those who did
MEDICATION TRIALS: The FDA has accepted Biogen’s application for aducanumab, an investigational treatment for Alzheimer’s, and even granted it Priority Review, with an action date
GENETICS & ALZHEIMER’S: Women’s second “X” chromosome provides them with more longevity, and researchers are finding they also have extra protection against Alzheimer’s as well,
The “glymphatic system” removes brain waste. It may be a powerful new target to treat Alzheimer’s. Learn why scientists believe Alzheimer’s may arise when the system is not doing its cleaning properly.
Plaques are the best-known Alzheimer’s culprit. Cambridge scientists have figured out the 7 steps to forming these plaques. Find out how targeting the formation of these “oligomers” may hold the key to a cure.
UCLA researchers found active people build 5% more gray matter in their brain. See how this prevents Alzheimer’s.
Here’s a good activity caregivers can use easily, contributed by one of our readers. It’s a simple game, great in mid-stage Alzheimer’s.
Meet Marley, a THERAPAWS therapy dog, helping the elderly that suffer from dementia. See pet therapy at work.
Alzheimer’s is the most common type of dementia, but it is just one cause. In this short Q & A, watch Stanford Neurologist Dr. Kerchner explain the importance of getting an accurate diagnosis.
Learn about The Alzheimer’s Society of Canada’s campaign to bust the stigma of dementia.
Discover 6 easy ways you can make a difference.
No spam, only news and updates.
